DRUG MANAGEMENT GROUP SL
Company details
- Active NIF/CIF: B98696644
-
-
-
-
Address: Carrer d'Isaac Peral, 9, 46024 València, Valencia, España See in map
-
-
Featured products:
More information on DRUG MANAGEMENT GROUP SL
-
08/03/2016 | BORME act no.: 109789 | Register: VALENCIAPérdida del caracter de unipersonalidad
-
08/03/2016 | BORME act no.: 109790 | Register: VALENCIACeses/Dimisiones
-
08/03/2016 | BORME act no.: 109790 | Register: VALENCIANombramientos
-
08/03/2016 | BORME act no.: 109790 | Register: VALENCIACambio de domicilio social
-
28/01/2015 | BORME act no.: 37814 | Register: VALENCIAConstitución
-
28/01/2015 | BORME act no.: 37814 | Register: VALENCIADeclaración de unipersonalidad
-
28/01/2015 | BORME act no.: 37814 | Register: VALENCIANombramientos
Other information
The CIF of DRUG MANAGEMENT GROUP SL is B98696644 and its current business status is active. Its economic sector is within the CNAE 6201 - Actividades de programación informática. Its SIC classification is 7372 - Programación de ordenadores y software.
DRUG MANAGEMENT GROUP SL employs approximately Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Valencia. To date, it has 3 registration charges. Its most recent announcement in the Borme was published on 08/03/2016 and its last deposit of ordinary annual accounts corresponds to the year -.
You can access the contact information of DRUG MANAGEMENT GROUP SL, such as the telephone number, postal address, and website, in the Company Data section.
If you wish to obtain more information about DRUG MANAGEMENT GROUP SL, you can review one of our available financial reports, the Annual Accounts of the company, or check if it has any registered payment incidents in the RAI delinquency file.
The financial, commercial, and legal information of DRUG MANAGEMENT GROUP SL comes from official data sources and is automatically updated every day.
Do you want to know more about DRUG MANAGEMENT GROUP SL??
Find out more about this company by consulting these reports: